New technologies rarely fail because the science is wrong. They fail, or cause harm, because institutions are not ready for them: rules written for older technologies, procurement that rewards the familiar, public bodies without the skills to evaluate what they are buying, and benefits that accrue to some while risks fall on others. At the same time, excessive caution has its own costs, leaving public problems unsolved and capability concentrated in a few places.
The difficulty is structural. Innovation is uncertain by nature, so its effects can only be partly known in advance. Decisions about research funding, standards, regulation and adoption are made by different institutions on different timescales, and the lessons from one pilot seldom reach the next. Frontier technologies such as artificial intelligence, biotechnology, quantum and robotics now cross sectors and borders faster than any single institution can follow.
Governing innovation well therefore means building the capacity to experiment responsibly, evaluate honestly, share what was learned and keep decisions with the authorities accountable for them. That is the field Innovation Nexus works in.
Why now: governed experimentation is spreading, from regulatory sandboxes to the AI testing regimes foreseen under the European Union AI Act (2024), and institutions need to know what a trial proved and what it did not. Innovation Nexus convenes the institutions that run and oversee trials, and a governed trial can be exercised in Universe under controlled conditions; reviewed lessons can inform Reports and common evaluation practice can be proposed to the Nexus Standards.